<DOC>
	<DOCNO>NCT00072293</DOCNO>
	<brief_summary>RATIONALE : Surgery remove lymph node armpit patient sentinel lymph node micrometastases may remove cancer cell spread tumor breast . It yet know whether surgery remove primary tumor effective without axillary lymph node dissection . PURPOSE : This randomized phase III trial study surgery axillary lymph node dissection see well work compare surgery alone treat woman node-negative breast cancer sentinel lymph node micrometastases .</brief_summary>
	<brief_title>Surgical Resection With Without Axillary Lymph Node Dissection Treating Women With Node-Negative Breast Cancer Sentinel Lymph Node Micrometastases</brief_title>
	<detailed_description>OBJECTIVES : - Compare disease-free survival woman clinically node-negative breast cancer sentinel lymph node micrometastases treat surgical resection without axillary dissection . - Compare overall survival patient treat regimen . - Assess sit recurrence , particularly reappearance disease undissected axilla . - Assess long-term surgical complication patient treat regimen . OUTLINE : This multicenter study . Patients stratify accord participate center , menopausal status ( pre- v postmenopausal ) , preoperative sentinel node biopsy ( yes v ) . Patients follow every 4 month 1 year , every 6 month 4 year , annually thereafter .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasm Micrometastasis</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Clinical , mammographic , ultrasonographic , pathologic diagnosis unicentric unifocal breast carcinoma Largest tumor lesion â‰¤ 5 cm Palpable nonpalpable breast lesion Preoperative radioactive occult lesion localization , hook wire , method localization require nonpalpable lesion Prior ( preoperative ) plan ( intraoperative ) sentinel node biopsy require At least 1 micrometastatic ( i.e. , great 2 mm ) sentinel lymph node extracapsular extension No clinical evidence distant metastases No suspicious manifestation metastasis rule xray , MRI , CT scan , include follow : Skeletal pain unknown cause Elevated alkaline phosphatase Bone scan show hot spot No palpable axillary lymph node ( ) No Paget 's disease without invasive cancer Hormone receptor status : Estrogen receptor progesterone receptor know PATIENT CHARACTERISTICS : Age Any age Sex Female Menopausal status Any status Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic See Disease Characteristics Renal Not specify Other Not pregnant nursing No prior concurrent malignancy except follow : Adequately treat basal cell squamous cell skin cancer Adequately treat carcinoma situ cervix Adequately treat situ melanoma Contralateral ipsilateral carcinoma situ breast No psychiatric , addictive , disorder may compromise ability give informed consent Geographically accessible followup PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery See Disease Characteristics Other No prior systemic therapy breast cancer More 1 year since prior chemopreventive agent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>stage IA breast cancer</keyword>
	<keyword>stage IB breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>estrogen receptor-negative breast cancer</keyword>
	<keyword>estrogen receptor-positive breast cancer</keyword>
	<keyword>progesterone receptor-negative breast cancer</keyword>
	<keyword>progesterone receptor-positive breast cancer</keyword>
</DOC>